Safety and efficacy of G-CSF after allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide: clinical and in vitro examination of endothelial activation-Reference-Cited by-同舟云学术

Safety and efficacy of G-CSF after allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide: clinical and in vitro examination of endothelial activation

Published:2024-08-08 Issue: Volume: Page:
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Escribano-Serrat Silvia^ORCID,Pedraza Alexandra,Suárez-Lledó María,Charry Paola^ORCID,De Moner Blanca,Martinez-Sanchez Julia,Ramos Alex,Ventosa-Capell Helena,Moreno Cristina,Guardia Laia,Monge-Escartín Inés,Riu Gisela,Carcelero Esther,Cid Joan^ORCID,Lozano Miquel^ORCID,Gómez Pilar,García Estefanía,Martín Lidia,Carreras Enric^ORCID,Fernández-Avilés Francesc,Martínez Carmen^ORCID,Rovira Montserrat,Salas María Queralt^ORCID,Díaz-Ricart Maribel^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41409-024-02388-y.pdf

Reference41 articles.

1. Pedraza A, Jorge S, Suárez-Lledó M, Pereira A, Gutiérrez-García G, Fernández-Avilés F, et al. High-dose cyclophosphamide and tacrolimus as graft-versus-host disease prophylaxis for matched and mismatched unrelated donor transplantation. Transpl Cell Ther. 2021;27:619.e1–619.e8.

2. Salas MQ, Pedraza A, Charry P, Suárez-Lledó M, Rodríguez-Lobato LG, Brusosa M, et al. Post-transplantation cyclophosphamide and tacrolimus for graft-versus-host disease prevention after allogeneic hematopoietic cell transplantation from HLA-matched donors has more advantages than limitations. Transpl Cell Ther. 2024;30:213.e1–213.e12.

3. Salas MQ, Charry P, Pedraza A, Martínez-Cibrian N, Solano MT, Domènech A, et al. PTCY and tacrolimus for GVHD prevention for older adults undergoing HLA-matched sibling and unrelated donor AlloHCT. Transpl Cell Ther. 2022;28:489.e1–489.e9.

4. Luznik L, O’Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transpl. 2008;14:641–50.

5. Nakamae H. Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide. Int J Hematol. 2022;116:465–81.